Exhibit 99.1
DATE: November 3, 2010
FOR IMMEDIATE RELEASE
AMERICAN MEDICAL SYSTEMS ANNOUNCES THIRD QUARTER 2010 FINANCIAL RESULTS
    Third quarter sales of $124.0 million grows 0.6%; up 2.9% excluding impact of currency and previously divested Uterine Health product line
 
    Non-GAAP adjusted EPS of $0.29 grows 7.4% over prior year
MINNEAPOLIS, November 3, 2010 — American Medical Systems Holdings, Inc. (NASDAQ: AMMD) reported sales of $124.0 million for the third quarter of 2010, a 0.6 percent increase over sales of $123.2 million in the comparable quarter of 2009. The strengthening of the U.S. dollar compared to the third quarter of 2009 negatively affected revenue comparisons for the quarter by $1.4 million. Adjusting for the impact of foreign currency results in third quarter revenue growth of 1.8 percent over the same quarter last year. Further adjusting revenue for the impact of the Her Option® uterine health product line, which was sold during the first quarter of 2010, results in constant currency growth of 2.9 percent.
The Company reported third quarter net income of $18.6 million, or $0.24 per share. This compares to net income and earnings per share in the same quarter last year of $28.6 million, or $0.38, which included a $17.4 million gain on the sale of the Ovion technology and a $5.6 million gain on the exchange of convertible notes. Non-GAAP adjusted earnings per share of $0.29 compares to $0.27 in the same quarter last year, a growth of 7.4%, and finishing at the top of guidance despite softer revenue than planned. Non-GAAP adjusted earnings per share excludes the gains noted above, as well as the impact of the amortization of intangible assets and amortization of financing costs, both significant non-cash items affecting comparability to other companies. A reconciliation of reported net income to non-GAAP adjusted net income is provided in the attached schedules.
Softness in the U.S. market was a significant driver in revenue falling short of earlier expectations, resulting in U.S. revenue growth of 2.1 percent compared to the same quarter last year. This compares to revenue growth of 10.6 percent in the U.S. in the first half of 2010.
Men’s Health sales of $55.2 million in the third quarter represented an increase of 0.9 percent on a reported basis compared to the same quarter last year and 2.4 percent on a constant currency basis, with the Male Continence product line growing in mid-single digits and the Erectile Restoration product line experiencing relatively flat growth. The BPH Therapy business declined 2.9 percent on a reported basis and 1.7 percent on a constant currency basis, to $26.9 million during the quarter. Sales were negatively impacted as customers awaited the launch of the MoXy™ Liquid Cooled Fiber which did not occur until late in the last week of the third quarter. The Women’s Health business, excluding the Her Option® product line that was sold in the first quarter, increased 6.0 percent on a reported basis and 6.8 percent on a constant currency basis to $41.2 million in the third quarter. The Pelvic floor repair product line, which continued its strong performance driven by the success of both the Elevate® anterior and posterior systems was partially offset by flat sales in the Female Continence product line.
“We were impacted more significantly than anticipated in the third quarter by softness in U.S. procedure volume. In addition, we experienced a longer than expected validation process to

 


The following information was filed by American Medical Systems Holdings Inc on Wednesday, November 3, 2010 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the information in the accompanying 10-Q Quarterly Report statement of earnings and operation as management may choose to highlight particular information in the press release.

View differences made from one quarter to another to evaluate American Medical Systems Holdings Inc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by American Medical Systems Holdings Inc.

Continue

Never Miss A New SEC Filing Again


Real-Time SEC Filing Notifications
Screenshot taken from Gmail for a new 10-K Annual Report
Last10K.com Member Feature

Receive an e-mail as soon as a company files an Annual Report, Quarterly Report or has new 8-K corporate news.

Continue

We Highlighted This SEC Filing For You


SEC Filing Sentiment Analysis - Bullish, Bearish, Neutral
Screenshot taken from Wynn's 2018 10-K Annual Report
Last10K.com Member Feature

Read positive and negative remarks made by management in their entirety without having to find them in a 10-K/Q.

Continue

Widen Your SEC Filing Reading Experience


Increased Reading Area for SEC Filings
Screenshot taken from Adobe Inc.'s 10-Q Quarterly Report
Last10K.com Member Feature

Remove data columns and navigations in order to see much more filing content and tables in one view

Continue

Uncover Actionable Information Inside SEC Filings


SEC Filing Disclosures
Screenshot taken from Lumber Liquidators 10-K Annual Report
Last10K.com Member Feature

Read both hidden opportunities and early signs of potential problems without having to find them in a 10-K/Q

Continue

Adobe PDF, Microsoft Word and Excel Downloads


Download Annual and Quarterly Reports as PDF, Word and Excel Documents
Screenshots of actual 10-K and 10-Q SEC Filings in PDF, Word and Excel formats
Last10K.com Member Feature

Export Annual and Quarterly Reports to Adobe PDF, Microsoft Word and Excel for offline viewing, annotations and analysis

Continue

FREE Financial Statements


Download Annual and Quarterly Reports as PDF, Word and Excel Documents
Screenshot of actual balance sheet from company 10-K Annual Report
Last10K.com Member Feature

Get one-click access to balance sheets, income, operations and cash flow statements without having to find them in Annual and Quarterly Reports

Continue for FREE

Intrinsic Value Calculator


Intrinsic Value Calculator
Screenshot of intrinsic value for AT&T (2019)
Last10K.com Member Feature

Our Intrinsic Value calculator estimates what an entire company is worth using up to 10 years of financial ratios to determine if a stock is overvalued or not

Continue

Financial Stability Report


Financial Stability Report
Screenshot of financial stability report for Coco-Cola (2019)
Last10K.com Member Feature

Our Financial Stability reports uses up to 10 years of financial ratios to determine the health of a company's EPS, Dividends, Book Value, Return on Equity, Current Ratio and Debt-to-Equity

Continue

Get a Better Picture of a Company's Performance


Financial Ratios
Available Financial Ratios
Last10K.com Member Feature

See how over 70 Growth, Profitability and Financial Ratios perform over 10 Years

Continue

Log in with your credentials

or    

Forgot your details?

Create Account